Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)
An initial consultation establishes injury history, inflammatory markers, and organ function before any protocol is designed
For example, in tendon fibroblast cells, BPC-157 dramatically increases phosphorylation (activation) of FAK and paxillin, leading to more cell migration and survival at injury sites
For that reason, and to support a reduction in harmful farming practices for the climate, I chose to become vegetarian for a year in 2011, then pescetarian, then flexitarian for about 6 years